Skip to main content
Clinical Trials/JPRN-UMIN000040699
JPRN-UMIN000040699
Completed
Phase 2

Internet-based cognitive behavioral therapy for patients with obsessive-compulsive disorder: A rescue trial - A rescue trial of Internet-based cognitive behavioral therapy for obsessive-compulsive disorder

Research Center for Child Metnal Development, Chiba University0 sites12 target enrollmentJune 10, 2020

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Research Center for Child Metnal Development, Chiba University
Enrollment
12
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 10, 2020
End Date
June 30, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Research Center for Child Metnal Development, Chiba University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Organic disorders of the brain (including dementia), psychotic disorders, bipolar disorders, serious psychiatric disorders such as drug dependence, etc. are complicated, and cognitive\-behavioral therapy is expected to be interrupted due to deterioration of these symptoms; 2\) The cognitive\-behavioral therapy is expected to be interrupted due to the imminent risk of suicide; 3\) Cognitive behavioral therapy is expected to be interrupted due to repeated antisocial behavior; 4\) Cognitive\-behavioral therapy is expected to be discontinued due to severe progressive physical illness; 5\) Due to severe stress reaction and dissociation symptoms due to acute stress disorder and post\-traumatic stress disorder, it is difficult to expose to feared subjects; 6\) There are significant problems due to attention deficit and hyperactivity disorderand autism spectrum disorder, and it is predicted that it will be difficult to receive stable treatment in the study conducted in this clinical study; 7\) Those who reject the ERP; 8\) Any other person who is judged by the investigator or the therapist to be unsuitable for the safe conduct of this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials